Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK256066 and Fluticasone Propionate in Seasonal Allergic Rhinitis
NCT00612820Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK256066 in seasonal allergic rhinitis (SAR) (3 arms), sponsored by GSK. Primary endpoint: Total Nasal Symptom Score at Day 2. Started Jan 2008; status: completed.
02
Drugs
GSK256066
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00612820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612820.